Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Type2 Diabetes clinical trials
Every US clinical trial registered for Type2 Diabetes — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
21 US clinical trials · 4 currently recruiting
The research picture
Type2 Diabetes has 21 registered US clinical trials, 4 of them open to new participants right now — about 19% of the total.
- 4
- recruiting participants now
- 19%
- of trials open to enrollment
- 3
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Brigham and Women's Hospital
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
The University of Texas Health Science Center, Houston
NCT04206748
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Washington University School of Medicine
NCT05277558
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
Zabeen Mahuwala, MD
NCT03481283
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
The University of Texas Health Science Center at San Antonio
NCT05057806
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital
NCT05220917
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
Dana-Farber Cancer Institute
NCT04717050
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
University of Pennsylvania
NCT04323189
Type 2 Diabetes With Antiplatelet Drugs
Tabula Rasa HealthCare
NCT05053828
An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol
Novartis Pharmaceuticals
NCT03060577
Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes
Indiana University
NCT03371940
Dietary Approaches to Stop Hypertension for Diabetes
Johns Hopkins University
NCT04286555
A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2
Mayo Clinic
NCT04547790
Blueberry Consumption and Type 2 Diabetes
Albany Research Institute
NCT02972996
Eliminating Hepatitis C Virus
Icahn School of Medicine at Mount Sinai
NCT03401697
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
University of Michigan
NCT02973477
Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy
Sansum Diabetes Research Institute
NCT04016584
The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans
Purdue University
NCT05349916
An Emotion-Focused Intervention for Glycemic Control in T2D
University of Chicago
NCT03553680
Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients
Model Clinical Research
NCT03324776
Hypoglycemia and Autonomic Nervous System Function- B2
Brigham and Women's Hospital
NCT03422471
Almond Butter and Fasting Glucose
Penn State University
NCT03826472
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Type2 Diabetes Trial Landscape
ClinicalTrials.gov lists 21 US studies indexed under Type2 Diabetes, and 4 of those are currently open to recruitment — roughly 19% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Type2 Diabetes shows 3 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Type2 Diabetes is led by Brigham and Women's Hospital with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 21 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Type2 Diabetes?
PlainTrial tracks 21 US clinical trials for Type2 Diabetes, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Type2 Diabetes?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.